Increased Serum Levels of Advanced Glycation Endproducts Predict Total, Cardiovascular and Coronary Mortality in Women with Type 2 Diabetes: a Population-based 18 Year Follow-up Study

Overview

Journal Diabetologia

Specialty Endocrinology

Date 2007 May 5

PMID 17479244

Citations 76

Authors

B K Kilhovd

A Juutilainen

S Lehto

T Ronnemaa

P A Torjesen

K F Hanssen

M Laakso

Affiliations

Soon will be listed here.

Abstract

Aims/hypothesis: AGEs, modification products formed by glycation or glycoxidation of proteins and lipids, have been linked to premature atherosclerosis in patients with diabetes. We investigated whether increased serum levels of AGEs predict total, cardiovascular (CVD) or CHD mortality in a population-based study.

Subjects And Methods: Serum levels of AGEs were determined by immunoassay in a random sample of 874 Finnish diabetic study participants (488 men, 386 women), aged 45-64 years. These participants were followed for 18 years for total, CVD and CHD mortality.

Results: Multivariate Cox regression models revealed that serum levels of AGEs were significantly associated with total (p = 0.002) and CVD mortality (p = 0.021) in women, but not in men. Serum levels of AGEs in the highest sex-specific quartile predicted all-cause (hazards ratio [HR] 1.51; 95% confidence intervals [CI], 1.14-1.99; p = 0.004), CVD (HR 1.56; 95% CI 1.12-2.19; p = 0.009), and CHD (HR 1.68; 95% CI 1.11-2.52; p = 0.013) mortality in women, even after adjustment for confounding factors, including high-sensitivity C-reactive protein.

Conclusions/interpretation: Increased serum levels of AGEs predict total and CVD mortality in women with type 2 diabetes.

Citing Articles

Association Between Skin Autofluorescence and Coronary Heart Disease in Chinese General Population: A Cross-Sectional Study.

Wu Q, Cheng Y, Liu H, Wang Y, Li B, Mu Y J Diabetes. 2025; 17(3):e70061.

PMID: 40024885 PMC: 11872386. DOI: 10.1111/1753-0407.70061.

Noninvasive Assessment of Vascular Function: From Physiological Tests to Biomarkers.

Higashi Y JACC Asia. 2025; 4(12):898-911.

PMID: 39802992 PMC: 11711812. DOI: 10.1016/j.jacasi.2024.09.015.

Glucose-Dependent Insulinotropic Polypeptide Inhibits AGE-Induced NADPH Oxidase-Derived Oxidative Stress Generation and Foam Cell Formation in Macrophages Partly via AMPK Activation.

Terasaki M, Yashima H, Mori Y, Saito T, Inoue N, Matsui T Int J Mol Sci. 2024; 25(17).

PMID: 39273671 PMC: 11395916. DOI: 10.3390/ijms25179724.

Extraction Effects on Roselle Functionalities: Antioxidant, Antiglycation, and Antibacterial Capacities.

Lai Y, Chiang Y, Jhan Y, Song T, Cheng M Foods. 2024; 13(14).

PMID: 39063256 PMC: 11275289. DOI: 10.3390/foods13142172.

Advanced glycation end products: Key mediator and therapeutic target of cardiovascular complications in diabetes.

Bansal S, Burman A, Tripathi A World J Diabetes. 2023; 14(8):1146-1162.

PMID: 37664478 PMC: 10473940. DOI: 10.4239/wjd.v14.i8.1146.

References

FRIEDEWALD W, Levy R, Fredrickson D . Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18(6):499-502. View

Kilhovd B, Juutilainen A, Lehto S, Ronnemaa T, Torjesen P, Birkeland K . High serum levels of advanced glycation end products predict increased coronary heart disease mortality in nondiabetic women but not in nondiabetic men: a population-based 18-year follow-up study. Arterioscler Thromb Vasc Biol. 2005; 25(4):815-20. DOI: 10.1161/01.ATV.0000158380.44231.fe. View

Vlassara H, Cai W, Crandall J, Goldberg T, Oberstein R, Dardaine V . Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy. Proc Natl Acad Sci U S A. 2002; 99(24):15596-601. PMC: 137762. DOI: 10.1073/pnas.242407999. View

Boulanger E, Wautier M, Wautier J, Boval B, Panis Y, Wernert N . AGEs bind to mesothelial cells via RAGE and stimulate VCAM-1 expression. Kidney Int. 2002; 61(1):148-56. DOI: 10.1046/j.1523-1755.2002.00115.x. View

Thornalley P, Battah S, Ahmed N, Karachalias N, Agalou S, Babaei-Jadidi R . Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry. Biochem J. 2003; 375(Pt 3):581-92. PMC: 1223712. DOI: 10.1042/BJ20030763. View

Reddy S, Bichler J, Wells-Knecht K, Thorpe S, Baynes J . N epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins. Biochemistry. 1995; 34(34):10872-8. DOI: 10.1021/bi00034a021. View

Valencia J, Mone M, Koehne C, Rediske J, Hughes T . Binding of receptor for advanced glycation end products (RAGE) ligands is not sufficient to induce inflammatory signals: lack of activity of endotoxin-free albumin-derived advanced glycation end products. Diabetologia. 2004; 47(5):844-52. DOI: 10.1007/s00125-004-1392-9. View

Brownlee M . Advanced protein glycosylation in diabetes and aging. Annu Rev Med. 1995; 46:223-34. DOI: 10.1146/annurev.med.46.1.223. View

Schmidt A, Hori O, Chen J, Li J, Crandall J, Zhang J . Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of.... J Clin Invest. 1995; 96(3):1395-403. PMC: 185762. DOI: 10.1172/JCI118175. View

10.

Kilhovd B, Berg T, Birkeland K, Thorsby P, Hanssen K . Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease. Diabetes Care. 1999; 22(9):1543-8. DOI: 10.2337/diacare.22.9.1543. View

11.

Vlassara H, Fuh H, Donnelly T, Cybulsky M . Advanced glycation endproducts promote adhesion molecule (VCAM-1, ICAM-1) expression and atheroma formation in normal rabbits. Mol Med. 1995; 1(4):447-56. PMC: 2229997. View

12.

Tan K, Chow W, Tam S, Bucala R, Betteridge J . Association between acute-phase reactants and advanced glycation end products in type 2 diabetes. Diabetes Care. 2003; 27(1):223-8. DOI: 10.2337/diacare.27.1.223. View

13.

Genuth S, Sun W, Cleary P, Sell D, Dahms W, Malone J . Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and.... Diabetes. 2005; 54(11):3103-11. PMC: 2622724. DOI: 10.2337/diabetes.54.11.3103. View

14.

Sims T, Rasmussen L, Oxlund H, Bailey A . The role of glycation cross-links in diabetic vascular stiffening. Diabetologia. 1996; 39(8):946-51. DOI: 10.1007/BF00403914. View

15.

Kostner G . Letter: Enzymatic determination of cholesterol in high-density lipoprotein fractions prepared by polyanion precipitation. Clin Chem. 1976; 22(5):695. View

16.

Kilhovd B, Giardino I, Torjesen P, Birkeland K, Berg T, Thornalley P . Increased serum levels of the specific AGE-compound methylglyoxal-derived hydroimidazolone in patients with type 2 diabetes. Metabolism. 2003; 52(2):163-7. DOI: 10.1053/meta.2003.50035. View

17.

Kass D, Shapiro E, Kawaguchi M, Capriotti A, Scuteri A, deGroof R . Improved arterial compliance by a novel advanced glycation end-product crosslink breaker. Circulation. 2001; 104(13):1464-70. DOI: 10.1161/hc3801.097806. View

18.

Kiuchi K, Nejima J, Takano T, Ohta M, Hashimoto H . Increased serum concentrations of advanced glycation end products: a marker of coronary artery disease activity in type 2 diabetic patients. Heart. 2000; 85(1):87-91. PMC: 1729572. DOI: 10.1136/heart.85.1.87. View

19.

Brownlee M . Biochemistry and molecular cell biology of diabetic complications. Nature. 2001; 414(6865):813-20. DOI: 10.1038/414813a. View

20.

Bucala R, Makita Z, Vega G, Grundy S, Koschinsky T, Cerami A . Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency. Proc Natl Acad Sci U S A. 1994; 91(20):9441-5. PMC: 44828. DOI: 10.1073/pnas.91.20.9441. View